Biodesix, Inc. (BDSX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Scott Hutton | President, CEO & Director | 614.92k | -- | 1972 |
| Ms. Robin Harper Cowie | CFO, Secretary & Treasurer | 390.3k | -- | 1980 |
| Mr. Kieran O'Kane | Chief Commercial Officer | 392.61k | -- | 1977 |
| Dr. Heinrich Röder | Founder & CTO | -- | -- | -- |
| Ms. Jessica Olbricht | Senior Director of Human Resources | -- | -- | -- |
| Dr. Gary Anthony Pestano Ph.D. | Chief Development Officer | -- | -- | 1967 |
| Ms. Bobbi Coffin | Chief Growth Officer | -- | -- | -- |
| Dr. James R. Jett M.D. | Co-Chief Medical Officer | -- | -- | -- |
| Dr. Steven C. Springmeyer | Co-Chief Medical Officer | -- | -- | -- |
| Mr. Christopher Vazquez | VP & Controller | -- | -- | -- |
Biodesix, Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 273
Description
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development, and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Corporate Governance
Upcoming Events
May 6, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC
Biodesix, Inc. Earnings Date
Recent Events
November 7, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
May 31, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission